Guardian Wealth Advisors (Minnesota)’s Pfizer PFE Stock Holding History

Guardian Wealth Advisors (Minnesota)’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,576	Closed	-$234K	–	70
2022 Q4	$234K	Buy	4,576 +2	+0%	+$96	0.21%	59
2022 Q3	$200K	Buy	4,574 +1	+0%	+$49	0.19%	59
2022 Q2	$240K	Buy	4,573 +2	+0%	+$102	0.22%	57
2022 Q1	$237K	Buy	4,571 +3	+0.1%	+$156	0.19%	59
2021 Q4	$270K	Buy	+4,568	New	+$226K	0.22%	56

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Guardian Wealth Advisors (Minnesota)'s PFE Position: Q1 2023 in Review

Guardian Wealth Advisors (Minnesota) sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,576 shares — an estimated $234K sold.

Guardian Wealth Advisors (Minnesota) first reported a position in PFE in Q4 2021 and held it in 5 quarters. The position peaked at $270K in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

Guardian Wealth Advisors (Minnesota) reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
Guardian Wealth Advisors (Minnesota) sold 4,576 Pfizer shares in Q1 2023, an estimated $234K.
Guardian Wealth Advisors (Minnesota) first reported a position in Pfizer in Q4 2021 and held it in 5 quarters.
Guardian Wealth Advisors (Minnesota)'s Pfizer position peaked at $270K in Q4 2021.
3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Guardian Wealth Advisors (Minnesota)'s 13F filing for Q1 2023, filed 3 May 2023.